BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9239093)

  • 1. [Cancer facts in 1997. Treatments and perspectives].
    Coeffic D; Noël G
    Soins; 1997 May; (615):12-23. PubMed ID: 9239093
    [No Abstract]   [Full Text] [Related]  

  • 2. Etiology, prevention, and treatment of breast, prostate, colorectal, and lung cancer.
    Mandel JS; Oken M
    Minn Med; 1998 May; 81(5):44-6, 71. PubMed ID: 9637858
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials referral resource. Non-small-cell lung cancer.
    Cheson BD
    Oncology (Williston Park); 1990 Feb; 4(2):51-63. PubMed ID: 2167113
    [No Abstract]   [Full Text] [Related]  

  • 4. Four major cancers that affect South Dakotans and the U.S. population: breast, colorectal, lung and prostate.
    Vogt HB; Hansen K
    S D Med; 2010; Spec No():5. PubMed ID: 20401982
    [No Abstract]   [Full Text] [Related]  

  • 5. [Old age and cancer. Treatment possibilities].
    Hupperets PS
    TVZ; 1989 Apr; 43(8):256-7. PubMed ID: 2500741
    [No Abstract]   [Full Text] [Related]  

  • 6. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
    Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A for effort: learning from the application of the GRADE approach to cancer guideline development.
    Brouwers MC; Somerfield MR; Browman GP
    J Clin Oncol; 2008 Mar; 26(7):1025-6. PubMed ID: 18309937
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreasing variation in the use of hospice among older adults with breast, colorectal, lung, and prostate cancer.
    Lackan NA; Ostir GV; Freeman JL; Mahnken JD; Goodwin JS
    Med Care; 2004 Feb; 42(2):116-22. PubMed ID: 14734948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lassoing hope. New frontiers in cancer treatment.
    Peters S
    Adv Nurse Pract; 1997 Aug; 5(8):55-8. PubMed ID: 9459958
    [No Abstract]   [Full Text] [Related]  

  • 10. Hospital differences in patient satisfaction with care for breast, colorectal, lung and prostate cancers.
    Sherlaw-Johnson C; Datta P; McCarthy M
    Eur J Cancer; 2008 Jul; 44(11):1559-65. PubMed ID: 18430563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical management of the most important cancers in older patients].
    Girre V; Brain E; Le Caer H; Ghesquières H; Peyrat P; Terret C; Droz JP
    Rev Prat; 2009 Mar; 59(3):347-58. PubMed ID: 19408878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials in a rural population: professional education aspects.
    Maurer LH; Davis T; Hammond S; Smith E; West P; Doolittle M
    J Cancer Educ; 2001; 16(2):89-92. PubMed ID: 11440069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of relationships in the experience of cancer: a re-working of the policy ideal of the whole-systems approach.
    Illingworth N; Forbat L; Hubbard G; Kearney N
    Eur J Oncol Nurs; 2010 Feb; 14(1):23-8. PubMed ID: 19748315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines for immunotherapy of breast cancer and prostate cancer: new developments and comparative aspects.
    Minev BR; Guo F; Gueorguieva I; Kaiser HE
    In Vivo; 2002; 16(6):405-15. PubMed ID: 12494883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer immunotherapy: phase II clinical studies with TG4010 (MVA-MUC1-IL2).
    Acres B
    J BUON; 2007 Sep; 12 Suppl 1():S71-5. PubMed ID: 17935281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
    Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting VEGF in cancer therapy.
    Donovan EA; Kummar S
    Curr Probl Cancer; 2006; 30(1):7-32. PubMed ID: 16443047
    [No Abstract]   [Full Text] [Related]  

  • 19. The anti-idiotype vaccines for immunotherapy.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of managed care on cancer trial enrollment.
    Gross CP; Krumholz HM
    J Clin Oncol; 2005 Jun; 23(16):3811-8. PubMed ID: 15923575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.